Home › Research › Brain scans and imaging
TMEM55B downregulation promotes neurodegeneration in Alzheimer’s disease models
Roy B, Contu VR, Jeziorek M, Friedman WJ, Wong C.. bioRxiv, 2026-10-24
Topic: Disease mechanisms in lab and animal studies
Plain-language summary
Lysosomal distribution is critical for numerous biological functions within the cell, including protein degradation in autophagosomes, cholesterol homeostasis, and cell invasion. Changes in the positioning of lysosomes and dysregulation of lysosomal trafficking are known to contribute to different human pathologies, such as lysosomal storage disease, neurodegeneration, and cancer. Here we report the critical role of the lysosomal T ransmembrane P rotein 55B (TMEM55B) in mediating neurodegeneration. Using human clinical-pathological datasets, transgenic flies and iPSC-derived neurons, we demonstrate that loss of function of dTMEM55 potentiates neuronal degeneration. We found that TMEM55B levels are lowered in severe Alzheimer’s Disease (AD) cases, validated from microarray, single neuron and total RNA Seq datasets from brain sections of the ROSMAP cohort. Our results demonstrates that loss of function of dTMEM55 results in accumulation of lysosomes in the fly’s larval neuronal axons, enhances Tau-mediated retinal degeneration, locomotory dysfunction, lethality, and cell death in the fly AD model. The iPSC-derived AD neurons exhibit reduced TMEM55B levels, autophagic flux defects and increased accumulation of phosphorylated Tau in the lysosomes, confirming the observations in the fly. Overall, our findings indicate that TMEM55B downregulation could contribute to neurodegeneration through defects in lysosomal transport, potentially hindering autophagic clearance of Tau. Our findings have significant relevance in validating the role of lysosomal proteins in normal lysosomal function and maintaining healthy neurons. This work supports continued research into lysosome-mediated neurodegeneration and may provide a basis for exploring potential therapeutic approaches for lysosome-associated neuronal disorders. Highlights TMEM55B expression is significantly reduced in postmortem brain tissues of patients with severe AD. Genetic loss of TMEM55B enhances Tau-mediated neurodegeneration in Drosophila , indicating a conserved neuroprotective function. TMEM55B regulates neuronal lysosomal positioning across species, and its loss disrupts lysosomal transport. iPSC-derived Alzheimer’s disease neurons exhibit late-stage TMEM55B downregulation concomitant with increased accumulation of pathological phosphorylated Tau. Impaired lysosomal trafficking provides a mechanistic link between TMEM55B loss and progressive neurodegeneration.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Roy, B., Contu, V. R., Jeziorek, M., Friedman, W. J., & Wong, C. (2026). TMEM55B downregulation promotes neurodegeneration in Alzheimer’s disease models. bioRxiv. https://doi.org/10.64898/2026.10.21.760809
Vancouver
Roy B, Contu VR, Jeziorek M, Friedman WJ, Wong C. TMEM55B downregulation promotes neurodegeneration in Alzheimer’s disease models. bioRxiv. 2026. doi:10.64898/2026.10.21.760809.
BibTeX
@article{roy2026-9b2290e4,
author = {Roy, B. and Contu, V. R. and Jeziorek, M. and Friedman, W. J. and Wong, C.},
title = {{TMEM55B downregulation promotes neurodegeneration in Alzheimer’s disease models}},
journal = {bioRxiv},
year = {2026},
doi = {10.64898/2026.10.21.760809},
url = {https://doi.org/10.64898/2026.10.21.760809}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- We found that TMEM55B levels are lowered in severe Alzheimer’s Disease (AD) cases, validated from microarray, single neuron and total RNA Seq datasets from brain sections of the ROSMAP cohort.
- Our results demonstrates that loss of function of dTMEM55 results in accumulation of lysosomes in the fly’s larval neuronal axons, enhances Tau-mediated retinal degeneration, locomotory dysfunction, lethality, and cell death in the fly AD model.
- Overall, our findings indicate that TMEM55B downregulation could contribute to neurodegeneration through defects in lysosomal transport, potentially hindering autophagic clearance of Tau.
- Our findings have significant relevance in validating the role of lysosomal proteins in normal lysosomal function and maintaining healthy neurons.
- Highlights TMEM55B expression is significantly reduced in postmortem brain tissues of patients with severe AD.
New to this subject? Start with our plain-English guide: Brain scans & tests →
Study details
- Evidence strengthModerate
How this study scored 16/100
Preprint — not yet peer-reviewed. It scored 24 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 15 of the 62 points we could judge it on, which is 24 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 2 / 10 | Tier 4 — not a peer-reviewed journal (bioRxiv) |
| Journal's citation record | 0 / 4 | Not a journal article, so the journal's record does not count |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 4 / 10 | Preprint — not yet peer-reviewed. Hosted on a preprint server. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 15 / 62 | Scored on 12 of 20 parts. We have no data for the rest, so they are left out: 15 of the 62 points we could judge it on is 24 out of 100. |
| Total | 24 / 100 | Capped to 16 because this is not a peer-reviewed article. |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Brain scans and imaging from nearby years
Also tagged “proteostasis”
241 studies in the library carry the topic tag “proteostasis”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 241 tagged studies.